已收盤 02-06 16:00:00 美东时间
+0.080
+1.56%
Ares Commercial Real Estate Corporation to Announce Fourth Quarter and Full Year Earnings Ares Commercial Real Estate Corporation will release its fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the New York Stock Exchange opens. The company will host a webc
01-28 05:30
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
Keefe, Bruyette & Woods analyst Jade Rahmani upgrades Ares Comml Real Est (NYSE:ACRE) from Market Perform to Outperform and raises the price target from $4.75 to $5.5.
2025-12-15 20:44
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
UBS analyst Douglas Harter maintains Ares Comml Real Est (NYSE:ACRE) with a Neutral and raises the price target from $4.5 to $5.
2025-11-15 01:10
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43
Ares Commercial Real Estate shares are trading higher after the company reporte...
2025-11-08 00:57
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
2025-11-07 19:11
Companies in the Real Estate sector have received a lot of coverage today as an...
2025-10-21 20:50
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
2025-10-10 11:36